GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Henry Schein HSIC · USD

Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States

S&P 500

Compare

88.41

+2.74%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Henry Schein

From its filings with the US Securities and Exchange Commission

SEC filings

Henry Schein is based in Melville, New York and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker HSIC. It is a member of the S&P 500. The SEC classifies its business as wholesale-medical, dental & hospital equipment & supplies. In the fiscal year to 27 December 2025, it reported revenue of $13.18bn and net income of $398.0m. At that date it held total assets of $11.21bn and shareholders' equity of $3.25bn.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
3 Nov 1995
Employees
25,000
Head office
135 DURYEA RD, MELVILLE, NY, 11747
Incorporated in
DE
Classification
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Filer status
Large accelerated filer

Leadership

Pay as last reported

  • Mr. Stanley BergmanChairman of the Board, Chief Executive Officer, Director, since 1980$11.6m
  • Mr. Ronald SouthChief Financial Officer, Senior Vice President$2.7m
  • Mr. Andrea AlbertiniChief Executive Officer - Global Distribution and Technology
  • Mr. R. BogganCo-Chief Executive Officer - Global Oral Reconstruction Group
  • Mr. Thomas PopeckChief Executive Officer - Henry Schein Products Group
  • Ms. Bianka WilsonCo-Chief Executive Officer - Global Oral Reconstruction Group
  • Mr. Michael EttingerChief Operating Officer, Executive Vice President$3.5m
  • Ms. Christine SheehyChief Human Resources Officer, Senior Vice President
  • Mr. Mark MlotekExecutive Vice President, Chief Strategic Officer, since 1994$3.6m
  • Mr. Christopher PendergastSenior Vice President, Chief Technology Officer
  • Ms. Kelly MurphySenior Vice President, General Counsel
  • Mr. David KochmanSenior Vice President, Chief Corporate Affairs Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
80
Environment
80
Social
99
Governance
61
Direct emissions (scope 1)
58,304 t
Energy emissions (scope 2)
20,890 t
Value chain emissions (scope 3)
776,259 t
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Henry Schein Inc has a diverse and extensive product portfolio, offering a wide range of medical, dental, and veterinary supplies. This allows the company to cater to the needs of various healthcare professionals and positions itself as a one-stop solution provider in the industry.
  • The company has a well-established and efficient distribution network, enabling it to efficiently deliver products to customers across geographies. This ensures timely availability of supplies and enhances customer satisfaction.

Weaknesses

  • Henry Schein Inc relies on a network of suppliers for its product offerings. Any disruption in the supply chain or the inability to secure necessary supplies could negatively impact the company's operations and customer satisfaction.
  • The healthcare industry is highly competitive, with numerous players competing for market share. Henry Schein Inc faces competition from both large multinational corporations and smaller regional distributors, making it essential for the company to continuously innovate and differentiate itself to maintain its market position.

Opportunities

  • With the growing emphasis on healthcare worldwide, there is an opportunity for Henry Schein Inc to expand its product offerings and capture a larger market share. The rising demand for healthcare supplies and equipment presents potential for the company to explore new markets and tap into emerging economies.
  • Technological advancements in the healthcare industry open doors for innovation and improved solutions. Henry Schein Inc can leverage these technological advancements to enhance its product portfolio, streamline operations, and provide value-added services to customers.

Threats

  • Compliance with complex healthcare regulations across different jurisdictions can pose challenges for Henry Schein Inc. Regulatory changes or non-compliance can impact the company's operations and require significant investments to stay updated and meet the necessary standards.
  • Economic fluctuations and uncertainties can affect the demand for healthcare products and services. Henry Schein Inc needs to monitor and adapt to changes in the economic environment to mitigate the potential impact on its business.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.